- Home
- NPKI vs QURE Comparison
NPKI vs QURE Comparison
Compare NPKI & QURE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NPKI
- QURE
- Stock Information
- Founded
- NPKI 1932
- QURE 1998
- Country
- NPKI United States
- QURE Netherlands
- Employees
- NPKI N/A
- QURE N/A
- Industry
- NPKI Metal Fabrications
- QURE Biotechnology: Pharmaceutical Preparations
- Sector
- NPKI Industrials
- QURE Health Care
- Exchange
- NPKI Nasdaq
- QURE Nasdaq
- Market Cap
- NPKI 726.0M
- QURE 725.4M
- IPO Year
- NPKI N/A
- QURE 2007
- Fundamental
- Price
- NPKI $8.54
- QURE $14.21
- Analyst Decision
- NPKI Strong Buy
- QURE Strong Buy
- Analyst Count
- NPKI 1
- QURE 10
- Target Price
- NPKI $12.00
- QURE $37.20
- AVG Volume (30 Days)
- NPKI 807.4K
- QURE 1.2M
- Earning Date
- NPKI 08-04-2025
- QURE 07-31-2025
- Dividend Yield
- NPKI N/A
- QURE N/A
- EPS Growth
- NPKI N/A
- QURE N/A
- EPS
- NPKI N/A
- QURE N/A
- Revenue
- NPKI $233,299,000.00
- QURE $20,201,000.00
- Revenue This Year
- NPKI $15.28
- QURE $27.16
- Revenue Next Year
- NPKI $9.62
- QURE $248.21
- P/E Ratio
- NPKI $17.62
- QURE N/A
- Revenue Growth
- NPKI 312.30
- QURE 6.30
- 52 Week Low
- NPKI $4.76
- QURE $3.73
- 52 Week High
- NPKI $8.88
- QURE $19.18
- Technical
- Relative Strength Index (RSI)
- NPKI N/A
- QURE 44.61
- Support Level
- NPKI N/A
- QURE $14.75
- Resistance Level
- NPKI N/A
- QURE $15.35
- Average True Range (ATR)
- NPKI 0.00
- QURE 1.05
- MACD
- NPKI 0.00
- QURE -0.27
- Stochastic Oscillator
- NPKI 0.00
- QURE 10.79
About NPKI NPK International Inc. Common Stock
NPK International Inc is a temporary worksite access solutions company that manufactures, sells, and rents recyclable composite matting products, along with a full suite of services, including planning, logistics, and site restoration. The company generates majority of revenue from the rental of recyclable composite matting systems, along with related site construction and services to customers in various markets including power transmission, oil and natural gas exploration and production, pipeline, renewable energy, petrochemical, construction and other industries within the United States and United Kingdom.
About QURE uniQure N.V.
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.